Tamiful Injection

Adult administration

For children over 11 years and adults, gently shake the medication with 5 mL of sterile water for injection, then mix it within 5 minutes into 500～1,000 mL of glucose injection solution, physiological saline injection solution, or similar intravenous fluids to administer as a drip intravenous injection once daily.

Child administration

For children over 11 years and adults, gently shake the medication with 5 mL of sterile water for injection, then mix it within 5 minutes into 500～

Use caution when administering this medication to women in the first three months of pregnancy or those who may become pregnant, as administering more than 5,000 IU of Vitamin A can pose a risk of congenital malformations. People who are allergic to the ingredients in this medicine or who have hemophilia should not use this medication. Patients with hypercalcemia or impaired kidney function may experience worsened conditions due to the Vitamin D present in this drug; thus, they should be carefully monitored through blood tests and used with caution. This medication has not established safety and efficacy in children under 11 years of age, so caution is required when using it. In the event of overdose, hypersensitivity reactions to Vitamins A and D or severe allergic reactions may occur; if unusual symptoms arise, immediately discontinue use and consult medical personnel. With prolonged use, Vitamins A and D may accumulate in the body, making regular testing important. Interactions with other medications may occur, particularly with certain diuretics, antibiotics, calcium salts, Vitamin K, and Levodopa, hence caution is necessary when used in conjunction with these. Pregnant or nursing women must adhere to appropriate doses to avoid side effects arising from vitamin overdose. Elderly individuals may have impaired body functions; therefore, careful dosage adjustments should be made. This medication may affect urine glucose tests or other urine test results, so inform medical personnel when undergoing testing. Do not reuse any remaining medication after use; dispose of it immediately, and since it contains light-sensitive ingredients, store it protected from light. Store out of reach of children, avoid freezing, and it is preferable to keep it refrigerated. This medication should be stored in its original container, as transferring it to another container may pose risks of misuse or deterioration of quality.

Serious side effects

• Shock
• anaphylactic symptoms
• hypotension
• altered consciousness
• respiratory distress
• cyanosis

Mild side effects

• Itching
• sweating
• hypotension
• altered consciousness
• cyanosis
• nausea
• chest discomfort
• facial flushing
• dizziness
• syncope

This medication must be stored in a sealed container to prevent exposure to air. Additionally, it is important to store it in a refrigerator at a temperature between 2°C and 8°C to maintain freshness and effectiveness.

Appearance

A freeze-dried injection in a brown vial containing yellow powder

Package unit

10 vials (10 vials per pack)